Based on mutational signatures (somatic substitution, insertion/deletion, and rearrangement patterns) as well as genomic scars, HRDetect is an additional assay to predict BRCA1/2 deficiency and was tested successfully in independent cohorts of patients with BC, OvCa and PaC [27]. Here, BRCA1 is linked to breast cancer.